Filing Flows › Nexgel (NXGL) › Q2 2026
Nexgel (NXGL) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 17, 2026
Nexgel (NXGL) reported revenue of $3.7M for the second quarter 2026 (Q2 2026), +28% from a year earlier and +39% from the quarter before. Operating margin was -68.0%, net loss $3.6M (97.8% of revenue).
Nexgel, Q2 2026: revenue $3.7M (+28% year over year), operating margin -68.0%, net loss $3.6M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.7M | +39% | +28% |
| Operating profit | −$2.5M | — | — |
| Net earnings | −$3.6M | — | — |
| Operating cash flow | −$2.2M | — | — |
What changed
Revenue was $3.7M in Q2 2026, up 28% year over year and up 39% from the previous quarter.
Gross margin was 30.1%, down 13.5 points from Q2 2025. Operating costs exceeded revenue by $2.5M, an operating margin of -68.0%. Operating expenses grew 91% against revenue growth of 28%. The quarter ended with a net loss of $3.6M, wider than the previous quarter's $871K loss.
Operating cash flow was −$2.2M. Non-cash charges added back $827K of depreciation and amortization and $119K of share-based compensation. Working capital and other items added $463K.
Questions
What was Nexgel's revenue in the second quarter 2026?
Nexgel (NXGL) reported revenue of $3.7M for the second quarter 2026 (Q2 2026), +28% from a year earlier and +39% from the quarter before.
Was Nexgel profitable in the second quarter 2026?
Operating loss was $2.5M (-68.0% of revenue) and net loss $3.6M.
Source: Nexgel 10-Q on SEC EDGAR.